New genetic test predicts who benefits from hep C drugs: study

An analysis of genetic patterns in the hepatitis C virus may help predict which patients are likely to respond to treatment, researchers have found. About half of patients infected with the virus do not respond to the costly therapy that has "terrible" side-effects, study author says.

Read the whole article on CBC: Health

More from CBC: Health